Abstract
Abstract
Background
It has been reported that the complete heart block (CHB) in neonatal lupus (NL) cannot be reversed. This study reported a case of NL-CHB that was reversed by transcutaneous pacing and repeated plasmapheresis.
Case presentation
A 35+ 6-week male preterm baby was transferred to the neonatal intensive care unit of the Army Medical Center in May 2020 for slight cyanosis around the lips and nose. Two days after birth, a sudden decrease in heart rate was observed during electrocardiogram (EGG) monitoring. Physical examination revealed a bluish-purple discoloration around the lips and an irregular heartbeat. EGG showed the presence of isolated P (142 bpm) and QRS (78 bpm) waves, ventricular escape beats, and a diagnosis of NL-CHB. To reverse the condition, transcutaneous pacing and five sessions of plasmapheresis were performed. At a 1.5-year follow-up, the baby exhibited well-developed cardiac structure and normal neurodevelopment.
Conclusions
Transcutaneous pacing and repeated plasmapheresis might be possible to reverse CHB in NL.
Funder
National key research project for women and children health of China
Publisher
Springer Science and Business Media LLC
Subject
Immunology and Allergy,Rheumatology,Pediatrics, Perinatology and Child Health
Reference16 articles.
1. Diaz-Frias J, Badri T. Neonatal Lupus Erythematosus. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Talel Badri declares no relevant financial relationships with ineligible companies.2023.
2. Tsujii N, Miyazaki A, Sakaguchi H, Kagisaki K, Yamamoto T, Matsuoka M, et al. High incidence of dilated Cardiomyopathy after Right Ventricular Inlet Pacing in patients with congenital complete atrioventricular block. Circ J. 2016;80(5):1251–8.
3. Kikano SD, Killen SAS. Transient fetal atrioventricular block: a series of four cases and approach to management. J Cardiovasc Electrophysiol. 2022;33(10):2228–32.
4. Izmirly PM, Saxena A, Sahl SK, Shah U, Friedman DM, Kim MY, et al. Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system. Ann Rheum Dis. 2016;75(6):1161–5.
5. Miyakata S, Takeuchi K, Yamaji K, Kanai Y, Tsuda H, Takasaki Y. [Therapeutic plasmapheresis for the prevention of congenital complete heart block associated with anti-SS-A/Ro antibody and anti-SS-B/La antibody]. Ryumachi. 2001;41(4):726–35.